- Home
- STAA vs JQC Comparison
STAA vs JQC Comparison
Compare STAA & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- JQC
- Stock Information
- Founded
- STAA 1982
- JQC 2003
- Country
- STAA United States
- JQC United States
- Employees
- STAA N/A
- JQC N/A
- Industry
- STAA Ophthalmic Goods
- JQC Finance Companies
- Sector
- STAA Health Care
- JQC Finance
- Exchange
- STAA Nasdaq
- JQC Nasdaq
- Market Cap
- STAA 850.9M
- JQC 747.1M
- IPO Year
- STAA N/A
- JQC N/A
- Fundamental
- Price
- STAA $19.20
- JQC $5.51
- Analyst Decision
- STAA Hold
- JQC
- Analyst Count
- STAA 7
- JQC 0
- Target Price
- STAA $18.20
- JQC N/A
- AVG Volume (30 Days)
- STAA 690.3K
- JQC 714.6K
- Earning Date
- STAA 08-06-2025
- JQC 01-01-0001
- Dividend Yield
- STAA N/A
- JQC 11.13%
- EPS Growth
- STAA N/A
- JQC N/A
- EPS
- STAA N/A
- JQC N/A
- Revenue
- STAA $279,134,000.00
- JQC N/A
- Revenue This Year
- STAA N/A
- JQC N/A
- Revenue Next Year
- STAA $27.83
- JQC N/A
- P/E Ratio
- STAA N/A
- JQC N/A
- Revenue Growth
- STAA N/A
- JQC N/A
- 52 Week Low
- STAA $13.50
- JQC $4.82
- 52 Week High
- STAA $42.17
- JQC $5.65
- Technical
- Relative Strength Index (RSI)
- STAA 64.07
- JQC 63.47
- Support Level
- STAA $16.80
- JQC $5.41
- Resistance Level
- STAA $19.37
- JQC $5.52
- Average True Range (ATR)
- STAA 0.62
- JQC 0.04
- MACD
- STAA 0.26
- JQC -0.00
- Stochastic Oscillator
- STAA 93.63
- JQC 79.17
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest
Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.